Recurrent hemarthroses rate one year [clinicaltrials_resource:5ea66008d461bfebc326e13954f5cf2e]
The efficacy of intra-articular bevacizumab injection for secondary prevention of recurrent hemarthroses for hemophilia patients who has had target joints with chronic synovitis. The efficacy will be measure by the recurrent hemarthroses rate after the investigational therapy
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Recurrent hemarthroses rate one year [clinicaltrials_resource:5ea66008d461bfebc326e13954f5cf2e]
The efficacy of intra-articular bevacizumab injection for secondary prevention of recurrent hemarthroses for hemophilia patients who has had target joints with chronic synovitis. The efficacy will be measure by the recurrent hemarthroses rate after the investigational therapy
Bio2RDF identifier
5ea66008d461bfebc326e13954f5cf2e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5ea66008d461bfebc326e13954f5cf2e
measure [clinicaltrials_vocabulary:measure]
Recurrent hemarthroses rate
time frame [clinicaltrials_vocabulary:time-frame]
description
The efficacy of intra-articula ...... er the investigational therapy
identifier
clinicaltrials_resource:5ea66008d461bfebc326e13954f5cf2e
title
Recurrent hemarthroses rate one year
@en
type
label
Recurrent hemarthroses rate on ...... 66008d461bfebc326e13954f5cf2e]
@en